José Antonio Vázquez García-rekin lankidetzan egindako argitalpenak (24)

2016

  1. Prevalencia, diagnóstico, tratamiento y control de la hipertensión arterial en España. Resultados del estudio Di@bet.es

    Revista Espanola de Cardiologia, Vol. 69, Núm. 6, pp. 572-578

2015

  1. Estimating cardiovascular risk in Spain by the European guidelines on cardiovascular disease prevention in clinical practice

    Revista Espanola de Cardiologia, Vol. 68, Núm. 5, pp. 417-425

2014

  1. Ambient temperature and prevalence of obesity in the spanish population: The di@bet.es study

    Obesity, Vol. 22, Núm. 11, pp. 2328-2332

  2. Prevalence of plasma lipid abnormalities and its association with glucose metabolism in Spain: The di@bet.es study

    Clinica e Investigacion en Arteriosclerosis, Vol. 26, Núm. 3, pp. 107-114

  3. Variable patterns of obesity and cardiometabolic phenotypes and their association with lifestyle factors in the Di@bet.es study

    Nutrition, Metabolism and Cardiovascular Diseases, Vol. 24, Núm. 9, pp. 947-955

2013

  1. Consumo de fármacos relacionados con el tratamiento de la diabetes mellitus y otros factores de riesgo cardiovascular en la población española. Estudio Di@bet.es

    Revista Espanola de Cardiologia, Vol. 66, Núm. 11, pp. 854-863

  2. Factors affecting levels of urinary albumin excretion in the general population of Spain: The Di@bet.es study

    Clinical Science, Vol. 124, Núm. 4, pp. 269-277

  3. Factors determining high-sensitivity C-reactive protein values in the Spanish population. Di@bet.es study

    European Journal of Clinical Investigation, Vol. 43, Núm. 1, pp. 1-10

  4. Mediterranean diet adherence in individuals with prediabetes and unknown diabetes: The Di@bet.es study

    Annals of Nutrition and Metabolism, Vol. 62, Núm. 4, pp. 339-346

  5. Prevalence of the metabolic syndrome in Spain using regional cutoff points for waist circumference: The di@bet.es study

    Acta Diabetologica, Vol. 50, Núm. 4, pp. 615-623

2012

  1. Iodine intake in the adult population. Di@bet.es study

    Clinical Nutrition, Vol. 31, Núm. 6, pp. 882-888

  2. Prevalence of diabetes mellitus and impaired glucose regulation in Spain: The Di@bet.es Study

    Diabetologia, Vol. 55, Núm. 1, pp. 88-93

2007

  1. Mutations in GCK and HNF-1α explain the majority of cases with clinical diagnosis of MODY in Spain

    Clinical Endocrinology, Vol. 67, Núm. 4, pp. 538-546

2004

  1. Epidemiology, clinical characteristics, outcome, morbidity and mortality in acromegaly based on the Spanish Acromegaly Registry (Registro Español de Acromegalia, REA)

    European Journal of Endocrinology, Vol. 151, Núm. 4, pp. 439-446

  2. Intraoperative monitoring of kinetic total serum calcium levels in primary hyperparathyroidism surgery

    Journal of the American College of Surgeons, Vol. 198, Núm. 4, pp. 519-524

2003

  1. Deficiencia de la hormona de crecimiento en el adulto: Efectos del tratamiento sustitutivo sobre la composición corporal y la calidad de vida relacionada con la salud

    Medicina Clinica, Vol. 120, Núm. 2, pp. 41-46

2000

  1. Excess iron storage in patients with type 2 diabetes unrelated to primary hemochromatosis [5]

    New England Journal of Medicine

1999

  1. Short- and long-term effect of a long-acting somatostatin analogue, lanreotide (SR-L) on metastatic gastrinoma

    Journal of Endocrinological Investigation, Vol. 22, Núm. 2, pp. 144-146

1997

  1. Factores asociados a la respuesta a agonistas dopaminergicos en prolactinomas

    Endocrinologia, Vol. 44, Núm. 8, pp. 280-283

1995

  1. Factors influencing the immediate and late outcome of Cushing's disease treated by transsphenoidal surgery: A retrospective study by the European Cushing's Disease Survey Group

    Journal of Clinical Endocrinology and Metabolism, Vol. 80, Núm. 11, pp. 3114-3120